Dupilumab in CRSsNP

Clinical trial NCT04678856 · COMPLETED

Trial details

NCT number: NCT04678856
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Rhinosinusitis Without Nasal Polyps Sinusitis Chronic Sinusitis Sinus Disorder Respiratory Disorder

Start date: 2020-12-02
Primary completion: 2023-11-14
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.